SHANTAL GIRON: Open Payments
NPI 1508531435 · LOS LUNAS, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 31 payments from 11 companies in 2025. Trend: 2023 $248 · 2024 $477 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $138 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| Exact Sciences Corporation | 3 | $57 |
| Viatris Specialty LLC | 1 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $44 |
| Inspire Medical Systems, Inc. | 1 | $35 |
| Astellas Pharma US Inc | 1 | $34 |
| Novo Nordisk Inc | 2 | $33 |
| Lilly USA, LLC | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
Products named: QULIPTA, YUPELRI, XIFAXAN, INSPIRE, Veozah, BREZTRI, The Cologuard Plus Collection Kit, Rybelsus.
Industry payments across NM — which companies pay providers there.
